Hypera Stock

Hypera Stock-Based Compensation

The Stock-Based Compensation (SBC) of Hypera (HYPE3.SA) as of Aug 19, 2026 is 22.98 M BRL. In the previous year, Stock-Based Compensation (SBC) was 33.20 M BRL — a change of -30.79% (lower).

Stock-Based Compensation

22.98 MBRL

YoY

-30.79%

Last updated:

Stock-Based Compensation (SBC) of Hypera is 2026 22.98 M BRL. Stock-Based Compensation (SBC) of Hypera was 2025 33.20 M BRL. It decreases by -30.79% lower compared to the previous year.
Access this data via the Eulerpool API

Hypera Stock analysis

What does Hypera do? Hypera SA is a Brazilian pharmaceutical company founded in 2001, specializing in the development, production, and distribution of drugs, generics, medical devices, and cosmetic products primarily for the Brazilian healthcare industry. Hypera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hypera stock

Stock-Based Compensation (SBC) of Hypera is 22.98 M BRL in 2026.

Stock-Based Compensation (SBC) of Hypera changed from 33.20 M BRL to 22.98 M BRL, representing a -30.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Hypera since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s BRL is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Hypera historically and in real time.

Access this data via the Eulerpool API

Cash Flow — Hypera

All Key Metrics — Hypera